4.2 Medical & Medication History: Drug–Nutrient Interactions and Supplements
Key Takeaways
CMS requires the dialysis comprehensive assessment to include comorbid conditions, a laboratory profile, immunization history and medication history (42 CFR 494.80(a)(1) and (a)(3)).
Fluoroquinolone antibiotics should be taken at least 2 hours before or 6 hours after phosphate binders and other calcium-, iron- or zinc-containing products because they form chelates.
Grapefruit, pomelo and Seville orange inhibit intestinal CYP3A4 and can sharply raise tacrolimus and cyclosporine levels; St. John's wort lowers them.
Patiromer should be separated from other oral drugs by 3 hours; sodium zirconium cyclosilicate by 2 hours from drugs with pH-dependent absorption.
Herbal products such as noni juice, alfalfa and nettle add potassium; star fruit is neurotoxic in advanced CKD; and creatine supplements raise serum creatinine without changing true GFR.
Why medical and medication history is its own exam topic
The October 2023 CSR outline lists medical and medications history as a separate assessment area. Two task statements sit behind it: evaluate drug–drug and drug–nutrient interactions and evaluate the prescribed medication and dietary supplement regimen, timing and adherence. The CMS Conditions for Coverage (42 CFR 494.80) require the facility's comprehensive assessment to include the patient's current health status and co-morbid conditions (§494.80(a)(1)) and a laboratory profile, immunization history and medication history (§494.80(a)(3)). KDOQI 2020 (statement 1.6.1) also tells dietitians to look beyond intake to medication use, knowledge, beliefs, food access, depression and cognition when planning nutrition interventions.
A typical maintenance dialysis patient takes a dozen or more prescription drugs, and phosphate binders make up a large share of the pill count. Many of these drugs change appetite, electrolytes, glucose or micronutrient status. Others fail if they are taken at the wrong time relative to food or to other drugs.
What to capture in the medical history
- Kidney history: cause of kidney disease (diabetes, hypertension, glomerulonephritis, polycystic kidney disease, obstruction), CKD stage or dialysis vintage and modality, residual urine output, prior transplants and access history.
- Comorbidities: diabetes and its complications (gastroparesis, retinopathy, neuropathy), heart failure and coronary disease, liver disease, GI disorders, cancer, depression and cognitive impairment.
- Events and procedures: recent hospitalizations, surgeries, amputations, infections, peritonitis episodes and wound status.
- Surgical history with nutrition consequences: bariatric surgery (fat malabsorption raises enteric oxalate absorption and kidney-stone risk; micronutrient deficiencies), bowel resection, gastrectomy.
- Dental and swallowing status, and vision and hand function, all of which affect the ability to prepare and eat food.
Medication reconciliation as a nutrition task
Medication reconciliation is also a quality measure: the PY 2028 ESRD Quality Incentive Program keeps a Medication Reconciliation (MedRec) reporting measure. The dietitian's part is to confirm what the patient actually takes, when, and with what. A "brown-bag" review, where the patient brings every bottle, box and supplement, often finds binders taken at bedtime, duplicated vitamins or an unreported herbal tea.
High-yield drug–nutrient interactions in renal practice
| Drug or class | Interaction or nutrition effect | What the dietitian does |
|---|---|---|
| Phosphate binders (calcium acetate or carbonate, sevelamer, lanthanum, sucroferric oxyhydroxide, ferric citrate) | Work only with food; can bind other drugs in the gut | Pair with meals and snacks; check separation from interacting drugs with the pharmacist |
| Fluoroquinolones (e.g., ciprofloxacin), tetracyclines | Chelated by calcium, iron, zinc, magnesium, aluminum and polymeric binders | Ciprofloxacin labeling: take it at least 2 hours before or 6 hours after these products |
| Levothyroxine | Absorption reduced by calcium, iron, sevelamer and lanthanum | Separate by several hours; watch TSH trends |
| Oral iron | Absorption reduced by calcium, binders, proton pump inhibitors, tea and coffee | Take apart from binders; ferric citrate is itself an iron source |
| Patiromer | Binds many oral drugs | Separate other oral drugs by at least 3 hours |
| Sodium zirconium cyclosilicate | Raises gastric pH transiently | Separate by 2 hours from drugs with pH-dependent absorption; adds about 400 mg sodium per 5 g |
| Sodium polystyrene sulfonate | Binds other drugs; bowel injury risk | Labeling advises separating other oral drugs by at least 3 hours (6 hours with gastroparesis) |
| ACE inhibitors, ARBs, mineralocorticoid antagonists, trimethoprim, calcineurin inhibitors, NSAIDs | Raise serum potassium | Rule out drug causes before tightening potassium restriction |
| Loop and thiazide diuretics | Potassium and magnesium losses | Monitor; potassium restriction may not be needed |
| SGLT2 inhibitors | Volume depletion; euglycemic ketoacidosis with prolonged fasting or very-low-carbohydrate diets | Avoid prolonged fasting plans; teach sick-day rules with the prescriber |
| Metformin | Lowers vitamin B12 over time; FDA labeling contraindicates use below eGFR 30 | Check B12; confirm eGFR-based dosing |
| Proton pump inhibitors | Hypomagnesemia; reduced B12 and non-heme iron absorption | Monitor magnesium, B12 and iron |
| Tacrolimus, cyclosporine | Grapefruit, pomelo and Seville orange raise blood levels; St. John's wort lowers them; hyperkalemia, hypomagnesemia, hyperglycemia | Counsel on these foods and herbs; monitor potassium, magnesium and glucose |
| Corticosteroids | Hyperglycemia, increased appetite, muscle catabolism, bone loss | Carbohydrate and weight counseling; calcium and vitamin D review |
| Warfarin | Effect changes with vitamin K intake | Keep vitamin K intake consistent; KDOQI 2020 advises no vitamin K supplements for patients on warfarin-type drugs |
| Opioids, calcium binders, oral iron | Constipation, which reduces colonic potassium excretion | Fiber, fluid within limits, bowel regimen |
Supplements and herbal products
Many patients do not think of teas, powders or "natural" remedies as medications, so ask directly and without judgment. High-risk products for people with kidney disease include:
- Potassium sources: potassium-chloride salt substitutes, noni juice, alfalfa, dandelion, nettle and horsetail preparations.
- Star fruit (carambola): contains a neurotoxin that accumulates in advanced CKD and can cause hiccups, confusion or seizures. Patients on dialysis should avoid it.
- Aristolochic acid: causes a progressive nephropathy. It has been found in imported herbal products despite FDA warnings.
- Licorice root (glycyrrhizin): mineralocorticoid-like effects cause sodium retention, hypertension and hypokalemia.
- Creatine supplements (and very large cooked-meat meals): raise serum creatinine and falsely lower creatinine-based eGFR.
- High-dose vitamin C: increases oxalate generation. Vitamin A-containing multivitamins add to retinol that already accumulates in CKD.
- Magnesium- or aluminum-containing antacids and laxatives, and sodium phosphate enemas: cause hypermagnesemia, aluminum loading or acute phosphate loads.
- High-dose biotin (often in hair and nail products): interferes with some immunoassays, including certain thyroid and troponin tests, so tell the lab.
Putting the history to work
Record medications and supplements in the client-history part of your assessment. Look for timing errors (binders at bedtime) and interacting pairs (ciprofloxacin swallowed with calcium acetate). Check whether a drug explains a lab abnormality before you change the diet. Send prescribing questions to the nephrologist or pharmacist. The dietitian changes food timing, counseling and supplement choices; the prescriber changes the drug.
A 52-year-old kidney transplant recipient on tacrolimus has a trough level that has climbed above the target range over two weeks without any dose change. Diet history shows the patient started drinking 12 ounces of fresh grapefruit juice every morning to "boost vitamin C." What is the most appropriate nutrition-related recommendation?
Continue the juice but take tacrolimus with a high-fat breakfast to slow its absorption.
Replace the juice with pomelo or Seville orange juice, which supply vitamin C without the interaction.
Stop the grapefruit juice, because grapefruit inhibits intestinal CYP3A4 and raises tacrolimus exposure, and notify the transplant team about the level.
Add a St. John's wort supplement to balance the enzyme inhibition caused by grapefruit.
A patient with CKD stage 4 has had serum potassium rise from 4.9 to 6.1 mEq/L over two months. Medications and kidney function are unchanged. During a brown-bag review the patient shows a bottle of noni juice taken twice daily "for energy" and a shaker of a salt substitute bought after being told to cut sodium. Which interpretation is most accurate?
Both products are likely potassium sources: noni juice is potassium-rich and most salt substitutes replace sodium chloride with potassium chloride.
Noni juice lowers potassium, so the salt substitute alone explains the change.
Neither product matters because intestinal potassium absorption stops in advanced CKD.
The rise must come from the ACE inhibitor, so the dietitian should recommend stopping it.
A hemodialysis patient is prescribed ciprofloxacin for a urinary infection while taking calcium acetate with each meal. The patient plans to swallow the antibiotic with lunch together with the binder. What counseling point is correct?
Take ciprofloxacin with the binder, because calcium improves antibiotic absorption.
Stop the binder for the whole course so that phosphorus control does not affect the infection.
Take ciprofloxacin at bedtime with a glass of milk to protect the stomach.
Take ciprofloxacin at least 2 hours before or 6 hours after the binder, because calcium and other polyvalent cations chelate the antibiotic and reduce its absorption.
Sections you finish are checked off in the contents.